Table 1.
Criteria for MIS-C diagnosis.
Agency | World Health Organization (WHO)23 | Centers for Disease Control and Prevention (CDC), USA | Royal College of Paediatrics and Child Health (RCPCH), UK22 | Proposed uniform definition |
---|---|---|---|---|
Age | 0–19 years | <21 years | Child (age not specified) | <21 years |
Fever | ≥3 days | Fever ≥38.0 °C for ≥24 h, or report of subjective fever lasting ≥24 h | Persistent fever >38.5 °C | Fever ≥38.0 °C for ≥3 days, or report of subjective fever lasting ≥3 days |
AND | At least two of the following | ≥2 organ system involvement | ≥2 organ involvement with specified signs | |
Clinical features |
1 Rash or bilateral non-purulent conjunctivitis or mucocutaneous inflammation signs (oral, hands, or feet) 2 Hypotension or shock 3 Features of myocardial dysfunction, pericarditis, valvulitis, or coronary abnormalities (including ECHO findings or elevated Troponin/NT-proBNP) 4 Evidence of coagulopathy (by PT, PTT, elevated D-dimers) 5 Acute gastrointestinal problems (diarrhea, vomiting, or abdominal pain) |
Evidence of clinically severe illness requiring hospitalization, with multisystem (≥2) organ involvement (cardiac, renal, respiratory, hematologic, gastrointestinal, dermatologic, or neurological) |
Evidence of single or multiorgan dysfunction (shock, cardiac, respiratory, renal, gastrointestinal, or neurological disorder) Most have oxygen requirement and hypotension Some have abdominal pain, confusion, conjunctivitis, cough, diarrhea, headache, lymphadenopathy, mucus membrane changes, neck swelling, rash, resp symptoms, sore throat, swollen hands and feet, syncope, and vomiting |
Cardiac: hypotension or shock, myocardial dysfunction, pericarditis, valvulitis, or coronary abnormalities, pericardial effusion (including ECHO findings or elevated Troponin/NT-proBNP) Gastrointestinal: diarrhea, vomiting, or abdominal pain Mucocutaneous: rash or bilateral non-purulent conjunctivitis, sore throat or mucocutaneous inflammation signs (oral, hands or feet) Hematologic: lymphadenopathy, thrombocytopenia, lymphopenia, evidence of coagulopathy (by PT, PTT, elevated D-dimers) Renal: acute kidney injury Respiratory distress, cough Neurological: confusion, headache, seizures |
AND | ||||
Markers of inflammation | Elevated markers of inflammation such as ESR, C-reactive protein, or procalcitonin | One or more of the following: an elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, procalcitonin, D-dimer, ferritin, lactic acid dehydrogenase (LDH), or interleukin 6 (IL-6), elevated neutrophils, reduced lymphocytes, and low albumin | Inflammation (neutrophilia, elevated CRP, and lymphopenia) Abnormal fibrinogen, elevated CRP, D-dimers or ferritin, hypoalbuminemia, lymphopenia, neutrophilia in most; normal neutrophils in some | One or more of the following (based on age-appropriate cut-offs): an elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, procalcitonin, D-dimer, ferritin, lactic acid dehydrogenase (LDH), or interleukin 6 (IL-6), elevated neutrophils, reduced lymphocytes, and low albumin |
AND | ||||
Absence of other etiology | No other obvious microbial cause of inflammation, including bacterial sepsis, staphylococcal or streptococcal shock syndromes | No alternative plausible diagnoses | Exclusion of any other microbial cause, including bacterial sepsis, staphylococcal or streptococcal shock syndromes, infections associated with myocarditis such as enterovirus | No alternative plausible diagnoses |
AND | ||||
Evidence of COVID-19 | Evidence of COVID-19 (RT-PCR, antigen test, or serology positive), or likely contact with patients with COVID-19 | Positive for current or recent SARS-CoV-2 infection by RT-PCR, serology, or antigen test; or exposure to a suspected or confirmed COVID-19 case within the 4 weeks prior to the onset of symptoms | SARS-CoV-2 PCR testing may be positive or negative | Positive for current or recent SARS-CoV-2 infection by RT-PCR, serology (not explained by prior immunization), or antigen test; or recent exposure to a suspected or confirmed COVID-19 case |